SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-109312
Filing Date
2016-04-01
Accepted
2016-04-01 16:06:15
Documents
4
Period of Report
2016-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-7752_18k.htm 8-K 26614
2 EX-10.1 a16-7752_1ex10d1.htm EX-10.1 23484
3 EX-99.1 a16-7752_1ex99d1.htm EX-99.1 8369
4 GRAPHIC g77521mmi001.jpg GRAPHIC 2863
  Complete submission text file 0001104659-16-109312.txt   63831
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 161547148
SIC: 2834 Pharmaceutical Preparations